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There is massive destruction of transcripts during the maturation of mouse oocytes. The objective of this project was to identify and
characterize the transcripts that are degraded versus those that are stable during the transcriptionally silent germinal vesicle (GV)-stage to
metaphase II (MII)-stage transition using a microarray approach. A system for oocyte transcript amplification using both internal and 3′-poly(A)
priming was utilized to minimize the impact of complex variations in transcript polyadenylation prevalent during this transition. Transcripts were
identified and quantified using the Affymetrix Mouse Genome 430 v2.0 GeneChip. The significantly changed and stable transcripts were analyzed
using Ingenuity Pathways Analysis and GenMAPP/MAPPFinder to characterize the biological themes underlying global changes in oocyte
transcripts during maturation. It was concluded that the destruction of transcripts during the GV to MII transition is a selective rather than
promiscuous process in mouse oocytes. In general, transcripts involved in processes that are associated with meiotic arrest at the GV-stage and the
progression of oocyte maturation, such as oxidative phosphorylation, energy production, and protein synthesis and metabolism, were dramatically
degraded. In contrast, transcripts encoding participants in signaling pathways essential for maintaining the unique characteristics of the MII-
arrested oocyte, such as those involved in protein kinase pathways, were the most prominent among the stable transcripts.
© 2006 Elsevier Inc. All rights reserved.Keywords: Oocyte maturation; Metaphase II; Transcriptome; Polyadenylation; MouseIntroduction
Fully grown mouse oocytes in Graafian follicles are
transcriptionally silent during the period before the resumption
of meiosis until after fertilization when most of the
transcriptional reactivation occurs at the 2-cell stage (Bou-
niolBaly et al., 1999; De La Fuente, 2006; Schultz, 1993;
Telford et al., 1990). Products of the oocyte genome support
oocyte growth and development before silencing and are also
stored for use during the silent period to support oocyte
maturation and the early stages of preimplantation embryo
development; see (De La Fuente, 2006; Telford et al., 1990)
for reviews. Massive destruction of transcripts occurs during⁎ Corresponding author. Fax: +1 207 288 6073.
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doi:10.1016/j.ydbio.2006.09.008oocyte maturation. Of an estimated 85 pg of mRNA present in
a GV-stage mouse oocyte, polyadenylated mRNA declines
during oocyte maturation by about 50 pg; about half
undergoes deadenylation and the other half, about 30% of
the total mRNA, undergoes degradation (Paynton et al., 1988).
However, little is known about which transcripts are degraded
and which are stable during the transition from the GV stage
to MII, and whether the degradation and stabilization of
certain transcripts is selective or random. Identification of the
transcripts that are lost versus those that are retained during
oocyte maturation could provide insights into processes
occurring during oocyte maturation, and those essential to
support maintenance of meiotic arrest at MII, fertilization, and
early development of the embryo.
Representative linear RNA amplification and microarray
technologies are powerful tools for studying global transcript
profiles in oocytes and embryos (Hamatani et al., 2004a, 2004b;
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2004; Zeng et al., 2004; Zeng and Schultz, 2005). However,
if the length of the 3′-poly(A) tails affects efficiencies of RNA
isolation or amplification, differential polyadenylation of
transcripts will confound analysis of degraded or stable
mRNA populations during the GV-to-MII transition. The
commonly used Affymetrix standard 2-cycle amplification
procedure for small sample preparation with low amounts of
RNA usually employs T7-Oligo(dT) primers. The efficiency
of in vitro transcription using such primers relies upon poly
(A) priming, and hence products are biased toward poly-
adenylated mRNA species. Therefore, use of this standard
protocol in a microarray study to compare the transcript
profiles between GV and MII oocytes would misrepresent
the relative transcript levels and the changes occurring
during oocyte maturation. It is known that some transcripts
become polyadenylated or deadenylated during oocyte
maturation (Gebauer et al., 1994; Huarte et al., 1987; Oh
et al., 2000; Paynton and Bachvarova, 1994; Sakurai et al.,
2005; Sheets et al., 1994; Tay et al., 2000). These changes
could distort the apparent relative steady state levels of
mRNAs before and after oocyte maturation if the adenyla-
tion status differs between the GV and MII stages and if this
status affects the efficiency of isolation or amplification
(Wang et al., 2004). Therefore, approaches to assess the
destruction or relative stability of specific mRNAs during
oocyte maturation must minimize the impact of variations in
adenylation.
Unlike the T7-Oligo(dT) primers used in Affymetrix's stan-
dard 2-cycle amplification procedure, the uniquely designed Full
Spectrum™ MultiStart Primers for in vitro transcription from
System Biosciences (Mountain View, CA) initiates cDNA syn-
thesis at multiple points along the mRNA with little or no bias
with respect to the length of poly(A) tails (for detailed
information, see http://www.systembio.com/Full_Spectrum_
MultiStart_RNA_Amplification.htm). Potential profiling errors
caused by a 3′-poly(A) biased amplification process can be
avoided when the Full Spectrum™ system is incorporated into
the Affymetrix 2-cycle amplification process instead of the
original T7-Oligo(dT) primers. Transcript profiles generated
from microarray studies using this modified RNA amplification
protocol would provide amore accurate perspective of the global
changes in populations of both degrading and stable transcripts
during oocyte maturation.
Here, we used the Full Spectrum™ primers system,
combined with Affymetrix Mouse Genome 430 v2.0 Gene-
Chip® arrays, to investigate the relative changes of transcripts
present in GV-stage versus MII-stage oocytes to identify
transcripts that are either lost or relatively stable during the
period of oocyte maturation in the mouse. We used the
Ingenuity Pathways Analysis and GenMAPP/MAPPFinder
software packages to define the biological functions and
pathways associated with the degraded or the stable transcripts.
By these means, we determined that transcript degradation was
selective and not random and hence were able to characterize
the major biological themes underlying the global changes in
oocyte transcripts during the process of maturation.Materials and methods
Mice
Immature 22- to 24-day-old B6SJLF1 female mice were used for all
experiments. Mice were produced and raised in the research colony of the
investigators at The Jackson Laboratory. All animal protocols were approved by
the Administrative Panel on Laboratory Animal Care at The Jackson Laboratory,
and all experiments were conducted in accordance with the NIH Guide for the
Care and Use of Laboratory Animals.
Isolation of immature and mature oocytes
Ovarian follicular development was stimulated by intraperitoneal
injection of 5 IU of eCG (EMD Biosciences, Inc., Calbiochem, La Jolla,
CA). Immature GV-stage oocytes were collected at 44–46 h post eCG
priming by puncturing large antral follicles on ovarian surface with a pair of
26-gauge needles. Released oocyte-cumulus cell complexes (OCCs) were
collected and cumulus cells surrounding the oocyte were removed
completely by passing OCCs several times through a hand-drawn small
fine glass pipette with an inner diameter slightly narrower than the oocyte.
Only those oocytes with an intact GV and no apparent sign of degeneration
were collected. To collect mature oocytes, eCG-primed mice were injected
with hCG (5 IU/mouse) 44–46 h after receiving eCG, and the oviducts were
removed 14 h post hCG injection. Ovulated OCCs were released by gently
teasing apart the ampulla of oviducts. Denuded oocytes were obtained by
incubating the mass of OCCs in medium containing 1 mg/ml of
hyaluronidase for about 3–5 min at 37°C. Mature oocytes with a visible
first polar body (hereafter termed MII oocytes) and no apparent sign of
degeneration were collected. Both GV and MII oocytes were washed
thoroughly in the collection medium to ensure that no cumulus cells were
present. Medium used for oocyte collection was MEM-α (Invitrogen
Corporation, Grand Island, NY) supplemented with 3 mg/ml of crystallized
lyophilized bovine serum albumin (Sigma, St. Louis, MO), 75 mg/l of
penicillin G (Sigma) and 50 mg/l streptomycin sulfate (Sigma). Milrinone
(Sigma), a selective inhibitor of oocyte-specific phosphodiesterase (PDE3), was
added into the medium at the concentration of 5 μM to prevent the GV-stage
oocytes from undergoing maturation. For consistency of the conditions for
oocyte collection, the same concentration of milrinone was also added in the
medium used for MII oocyte collection. Oocytes were finally transferred to a
1.5-ml centrifuge tube, re-suspended in the RNA extraction buffer supplied in
the PicoPure™ RNA Isolation Kit (Arcturus, Mountain View, CA), vortexed
and frozen in liquid nitrogen. Oocyte samples were temporarily stored at −80°C
until RNA isolation. Three sets of GV and MII oocyte samples were collected
and employed for microarray study. Four additional sets of oocyte samples were
collected and used for real-time RT-PCR analysis. Each sample contained
300 GVor MII oocytes that were pooled from 6 mice.
Oocyte RNA sample preparation and array processing
Total RNAwas extracted from oocytes using the PicoPure RNA Isolation Kit
according to the manufacturer's instruction. The RNA quality and yield of each
sample were determined using the Bioanalyzer 2100 and RNA 6000 Pico
LabChip assay (Agilent Technologies Inc, Palo Alto, CA) in combination with
Quant-iT™ RiboGreen Reagent according to supplied protocols (Invitrogen,
Carlsbad, CA). Ten nanograms of total RNA from each sample was employed in
the two-round cDNA synthesis and subsequent in vitro-transcription according to
the Two-Cycle Eukaryotic Target Labeling Assay (Affymetrix Expression Ana-
lysis Technical Manual: “ Section 2: Eukaryotic Sample and Array Processing”
(http://www.affymetrix.com/support/technical/manual/expression_manual.
affx)) with the following modifications. For the first and second cycle of cDNA
synthesis steps, Full Spectrum™ MultiStart Primers for in vitro transcription
(SystemBiosciences, Mountain View, CA) were used instead of Affymetrix's
standard T7-Oligo(dT) primer or random hexamers. Equal amounts, 15 μg, of
fragmented and biotin-labeled cRNA from each sample were then hybridized to
Affymetrix Mouse Genome 430 v2.0 GeneChip® arrays for 16 h at 45°C. Post-
hybridization staining and washing were performed according to manufacturer's
protocols using the Fluidics Station 450 instrument (Affymetrix).
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After the post-hybridization staining and washing, the arrays were scanned
with a GeneChip™3000 laser confocal slide scanner (Affymetrix) and the
images were quantified using Gene Chip Operating Software version 1.2
(GCOS, Affymetrix). Probe level data were imported into the R software
environment (http://www.r-project.org) and expression values were summarized
using the RMA (Robust MultiChip Average) function (Irizarry et al., 2003) in
the R/affy package with rma2 background adjustment, no inter-array
normalization and median polish summarization of perfect match values
(Gautier et al., 2004).
To account for the difference in starting RNA amount obtained from the
same number of GVand MII oocytes, and based on the fact that there is no new
transcriptional activity in the fully grown oocytes (De La Fuente, 2006), a
quantile normalization was performed based on a group of non-differentially
expressed genes that were sampled based on estimated normal mixture model
using expectation maximization (EM) algorithm (Gautier et al., 2004;
McLachlan and Krishnan, 1997). Probe sets that were considered absent in
both stages using Affymetrix MAS present/absent call and Fisher's combined p-
value (Hedges and Olkin, 1985; Mah et al., 2004) were removed from further
analysis. Using the R/maanova package (Wu et al., 2003a), an analysis of
variance (ANOVA) model was applied to the data, and F test statistics were
constructed along with their permutation p-values (Cui and Churchill, 2003; CuiTable 1
Primers used for real-time PCR analyses
Gene symbol RefSeq Forward primer sequence (5′-3′) R
Bmp15 NM_009757 GCACGATTGGAGCGAAAATG C
Calm2 NM_007589 GAGAAGCATTCCGTGTGTTTGATA G
Ccndbp1 NM_010761 CAAGTCCGTATTGCCATCGA A
Ccnh NM_023243 CACTTAATGCGGTTACGAAGAAGAG G
Clybl NM_029556 CCTTTGTGGAGACTGCAATGG C
Dedd NM_011615 AGCGAAAACGCCGGAAGT C
Dnajc2 NM_009583 CAGCTCATAAAGCAATGGTCTTGA G
Exosc8 NM_027148 TGCCGTCCTGATGGAAGAGA G
Fgf8 NM_010205 CAGGTCTCTACATCTGCATGAACAA T
G6pdx NM_008062 CTATGAAGCAGTCACCAAGAACATTC A
Gdf9 NM_008110 TCACCTCTACAATACCGTCCGG G
Gja1 NM_010288 GAACTCTCCTTTTCCTTTGACTTCAG C
OCBGLO V00879 GGGCAAGGTGAATGTGGAAG A
H1foo NM_138311 TGGAGGCCAGAAGGTCAAAC C
Has2 NM_008216 CGAGTCTATGAGCAGGAGCTG G
Hprt NM_013556 TTGCTGACCTGCTGGATTACAT A
Ina NM_146100 AGATCGCAGCTTACAGGAAGCT G
Lmna NM_001002011 TGTGGAAGGCGCAGAACAC T
Ly6e NM_008529 TGGGCATGGAGCAAGTTCA T
Mos NM_020021 CACCAAGCTCCGGAGATCCT C
Nalp5 NM_011860 TCAGAGACCTCCTCTCGGTAGATAA T
Ndufv1 NM_133666 GCCTCCAATTTGCAGGTAGCTAT C
Paip2 NM_026420 CCGACAGGATTCGTTGGCTA A
Plat NM_008872 CAACAGCGGCCTGGTACAA G
Polr2b NM_153798 TCCAAACCTACTCATTGGGAAAG G
Psmc2 NM_011188 ACTGACATTGAAGAAGGGATGAGAGT C
Ptgs2 NM_011198 CCCTTCCTCCCGTAGCAGAT T
Ptx3 NM_008987 TTGCTGAGACCTCGGATGAC G
Rpl19 NM_009078 CCGCTGCGGGAAAAAGAAG C
Rps17 NM_009092 GCGAGGAGATCGCCATTATC C
Rps9 NM_029767 CCCTGGCCAAGATCCGTAAG G
Spin NM_011462 CATGTACCAGCTCCTCGATGAC A
Statip1 NM_021448 CGGGTGATTCATTGGGAACT T
Tacc3 NM_011524 AGTGCTGGAGCCTTCCCATC T
Tnfaip6 NM_009398 ATACAAGCTCACCTACGCCGAA A
Xrcc5 NM_009533 CGGGACCTGAAGAAGCTGGT G
Zar1 NM_174877 CACCAGTAAGGTGTACTTCAAACAGTTC Get al., 2005). To account for potential multiple-testing problems, the family-wise
error rate (FWER) was controlled using a permutation-based one-step correction
(Cui and Churchill, 2003; Wu et al., 2003a). This allows for selecting transcripts
with very high statistical significance and thus reduces expected false-positive
rates. The transcripts in the microarray data set that were changed significantly
during the GV to MII transition were defined by the criteria of FWER p-value
<0.05. Instead of simply defining the complement of the significantly changed
transcripts as the stable transcripts, stringent criteria were used for clearly
identifying those that were stable on a sound statistical basis. In order to reduce
false positives: (1) the 95% confidence intervals contain log2 ratio=0 (no
change), (2) the lower and upper boundaries of the intervals are contained within
log2 ratio= −1 (fold change= −2) and log2 ratio=1(fold change=2). This
approach allows for the selection of transcripts having log2 ratios close to zero
with low biological and technical variation. Results were annotated using
information provided by Affymetrix (12/20/2005 release). Full data sets are
available at http://www.ncbi.nlm.nih.gov/geo/.
Pathway analysis
All gene identifiers and their corresponding FWER p-values, and fold
changes (MII relative to GV) were uploaded into IPA 3.1 (Ingenuity Pathway
Analysis, Ingenuity® System, http://www.ingenuity.com) and GenMAPP 2.0
(Gene Map Annotator and Pathway Profiler, http://www.genmapp.org)/everse primer sequence (5′-3′) Amplicon position Amplicon
size (bp)
GTACGCTACCTGGTTTGATGC 614–736 123
TTAACTTCTCGCCAAGGTTTGTC 331–424 94
GCATTCCGTACCAGCTTTCTC 282–374 93
TTAGAGAGAATCTACCAGGTCGTCATC 917–1033 117
TGCATCTAGGCAAAGACCCA 502–597 96
CGTCTCATGCTGGCAGTATT 607–705 99
CAAGTGAAGTAGTCATTGTCTCCTT 394–488 95
AGCAGAGCCATCCGCTGTA 433–517 85
CTCCAGCACGATCTCTGTGAATA 669–764 96
GTTGATTGGAGCTCTGTAGGTCTCT 785–895 111
AGCAAGTGTTCCATGGCAGTC 352–490 139
ATGTCTGGGCACCTCTCTTTC 91–188 98
CAGGTCCCCCAAAGGACTCG 101–200 100
CAAGGGCTTCGATTTCTCA 677–762 86
TGATTCCGAGGAGGAGAGACA 481–587 107
TGTCCCCCGTTGACTGATC 311–428 118
GATTGGGCAGTGGATTCAG 1228–1321 94
CAGTGAGCGCACCAGCTT 1258–1362 105
AATGGTCTTTCTCCTGGCATGA 160–262 102
TGCCACAGGGTGATTCCAA 868–948 81
TTCCCCACCACTCCATGAG 1957–2056 100
ACGCACCACAAACACATCA 599–701 103
TGGTTGGTGCTCGTTGTCG 52–121 70
AAATACAGGGCCTGCTGACA 297–393 97
CGGAGCAGAATACGTGAGAT 401–491 91
ACCTGCATCATGGTAACTGTTG 796–900 105
GAACTCTCTCCGTAGAAGAACCTTT 510–620 111
CGAGTTCTCCAGCATGATGA 222–374 153
AGCCCATCCTTGATCAGCTT 45–147 103
TCTCACAGGCCCTCTCTGAA 175–273 99
CAGGAGAGCATTGCCTTCA 198–287 90
CAACTTCTCCTGGCTCCCTTT 489–587 99
AGCGTGCACAGCACAAACA 256–346 91
GGCTCAACAGAAGGGGTCA 533–605 73
TCCATCCAGCAGCACAGACAT 201–319 100
CACTCTTGGATTCCCCACA 2177–2257 81
CAGGCACATCTAGTTCTTTTACAAC 885–996 112
Fig. 1. Distribution of transcripts at various magnitudes of difference in
expression levels between MII and GV oocytes. Transcripts, as represented by
Affymetrix probe sets, were categorized by fold changes in expression levels
between MII and GVoocytes. Only transcripts that were detected in either GVor
MII oocytes as determined by an Affymetrix “P” call as defined in the Materials
and methods section were subjected to the analysis. The number on the top of
each bar indicates the percentage of each corresponding group of transcripts in
total. The shaded portion of each bar indicates the number of transcripts whose
expression levels in MII oocytes were different from GVoocytes as determined
by FWER p-value <0.05. n.c.=no change.
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underlying the down-regulated and relatively stable transcripts during oocyte
maturation.
Real-time RT-PCR analysis
Real-time RT-PCR analyses were carried out using total RNA isolated from
four sets of GV and MII oocyte samples, in which each sample contained 300
oocytes. RNA isolation was accomplished using the RNeasy Micro Kit (Qiagen,
Valencia, CA). To normalize the potential variation between samples originating
from pipetting and RNA isolation processes, rabbit β-globin (OCBGLO) mRNA
(a generous gift from Dr. Richard Schultz, University of Pennsylvania) was
added into each oocyte sample at the beginning of RNA extracting process at a
concentration of 0.125 pg/oocyte. In vitro transcription was carried out using
QuantiTect® Reverse Transcription Kit (Qiagen) at 42°C for 15 min. Random
hexamer (Invitrogen, Grand Island, NY) was used in the RT reaction at the
concentration of 100 ng/20μl reaction to replace the original primermix included
in the RT kit. Real-time PCR was then conducted to quantify the steady-state
mRNA levels of the selected genes for validation using QuantiTect® SYBR
Green PCR Kits (Qiagen) on the ABI 7500 Real-time PCR System (Applied
Biosystems, Foster City, CA). The threshold cycle (Ct) was used for determining
the relative expression level of each gene, by normalizing to the Ct of OCBGLO.
The method of ddCt was used to calculate the relative fold change of each gene.
The calculating equation is as follows: fold change(MII vs. GV)=2
−ddCt, where
ddCt= (CtMII/GOI−CtGV/GOI)− (CtMII/OCBGLO−CtGV/OCBGLO). GOI: gene of
interest (the gene selected for real-time RT-PCR analysis). Because SYBR
Green binding is not sequence specific, careful design and validation of each
primer pair, as well as cautious manipulation of RNAwere undertaken to ensure
that only target gene sequence-specific, non-genomic products were amplified by
real-time PCR. To achieve this, primers were designed to either span or flank
introns. A dissociation curve analysis was performed at the end of the
amplification process in order to verify the specificity of the PCR products.
The same PCR products were also evaluated by agarose gel electrophoresis. The
sequence of each PCR product was finally verified by two-direction sequencing.
Information on the primers used for real-time PCR is shown in Table 1. In
addition, a DNase digestion step was incorporated in the RNA isolation process,
and isolated RNAwas first treated with a genomic DNAwipe out buffer supplied
in the RT Kit (Qiagen) before in vitro transcription. This buffer eliminates
genomic DNA contamination from starting RNA samples for in vitro
transcription.
Real-time RT-PCR experiments were repeated four times independently.
Data are presented as mean ± SEM. Student's t-test was conducted to evaluate
difference between the expression levels of GV and MII oocytes. p<0.05 was
considered significantly different.
Results and discussion
Extensive destruction of transcripts occurs in oocytes during
meiotic maturation yet there is only limited information on
which transcripts are degraded or relatively stable (Bachvarova
et al., 1985; Bettegowda et al., 2006; Lequarre et al., 2004;
Lonergan et al., 2003; Paynton et al., 1988; Stutz et al., 1998;
Zheng et al., 2005a, 2005b). A global perspective of the relative
changes in oocyte transcript profiles during the process of
maturation has been lacking. Here, using microarray and
bioinformatics approaches for analysis of gene ontology and
pathways, we assessed changes in transcript profiles in GV and
MII mouse oocytes, and investigated the biological themes
associated with the corresponding global changes. A modified
RNA linear amplification procedure in which the Full
Spectrum™ MultiStart Primers for in vitro transcription, a
primer set uniquely designed to initiate cDNA synthesis at
multiple points along the mRNAwith reduced bias of the length
of 3′-poly(A) tail, replaced the commonly used T7-Oligo(dT)primers whose priming efficiency is affected by the 3′-poly(A)
tail. This modified amplification protocol was used to reduce
potential profiling errors derived from the active mRNA
polyadenylation/deadenylation that occurs in oocytes during
maturation.
Global changes in oocyte transcripts during meiotic
maturation in vivo
The Affymetrix Mouse Expression 430v2.0 GeneChip
contains 45,037 probe sets that represent 14,484 full-length
genes, 9450 non-ESTs and 21,103 ESTs, according to the
manufacturer. In the present study, 21,646 probe sets were
detected as present in either GV or MII oocytes. The mean
relative changes of these transcripts during meiotic maturation
from GV to MII are shown in Fig. 1. Of all the present
transcripts, 3002 probe sets were identified to be significantly
changed using the criteria of FWER p-value <0.05, and 9260
probe sets were identified to be relatively stable using a separate
criteria for defining stable transcripts as described in Materials
and methods. Of particularly note, 2,957 probe sets were
significantly down-regulated, and they represent the over-
whelming majority (98.50%) of the changed transcripts.
Moreover, 61.12% of the total changed transcripts (1,838
probe sets) were down-regulated more than 4-fold in MII
oocytes. However, 1.5% of the changed transcripts (54 probe
sets) appeared to be up-regulated in MII oocytes, but real-time
PCR analysis suggested that this increase is artifactual (see
below section for further discussion of this issue).
It is important to note that FWER, rather than FDR (false
discovery rate), was utilized here to identify transcripts whose
expression levels become changed significantly during GV-to-
MII transition. Of the available methods for testing the
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controls for the possibility of making one or more type I error –
rejecting null hypothesis when the null hypothesis is true – in
the entire experiment. Although this method is quite stringent, it
allows for selecting specific transcripts with very high statistical
significance and thus reducing false-positive rates. This
conservative strategy for identification of significantly changed
transcripts is essential in the present study. This is because of the
difference in mRNA abundance between a GV and an MII
oocyte, and the problem is that the normalization method
employed here cannot eliminate all the artifacts inherent in the
equal loading of the microarrays (see below for more discussion
of this issue).
Although FWER is appropriate for identification of
drastically changed transcripts with low false-positive rate in
the significantly changed category, its high stringency will
probably leave some differentially expressed transcripts in the
not significantly changed category (Cui and Churchill, 2003).
Therefore, it is inappropriate to simply define the complement
of the significantly changed transcripts as the stable ones. A
separate strategy was therefore required to identify the stable
transcripts while reducing the incidence of false positives. The
criteria used in the present study for the stable transcripts met
this need and ensured the identification of the 9260 stable
transcripts with both high accuracy (their log2 ratios close to
zero) and high precision (low technical and biological variation)
(Woo et al., 2004). Thus, of the 21,646 probe sets that were
detected in oocytes, 3002 were determined to be significantly
changed and 9260 unchanged using the two methods of
statistical evaluation. This means that 7384 did not fall into
either category with certainty and were not used in the pathway
analyses.
Validation of the microarray data
Thirty-six transcripts were selected from the array expression
profile for further analysis by real-time RT-PCR. These 36
transcripts were categorized into 5 groups consisting of (A)
transcripts normally expressed in the expanded cumulus
oophorus but not in oocytes, i.e., Has2, Ptgs2, Ptx3 and
Tnfaip6; (B) transcripts polyadenylated during oocyte matura-
tion, i.e., Ccndbp1, G6pdx, Hprt1, Mos, Plat and Spin; (C)
transcripts expressed only or highly in mouse oocytes, i.e.,
Bmp15, Fgf8, Gdf9, H1foo, Nalp5 and Zar1; (D) transcripts
apparently up-regulated in MII oocytes as shown by the present
microarray data, i.e., Clybl, Ina and Ly6e; (E) transcripts that
were significantly down-regulated as shown by the present
array data and are linked to various specific biological functions
and cellular processes, i.e., Calm2, Ccnh, Dedd, Dnajc2, Ex-
osc8, Gja1, Lmna, Ndufv1, Paip2, Polr2b, Psmc2, Rpl19,
Rps9, Rps17, Statip1, Tacc3 and Xrcc5.
As shown in Fig. 2, for all the transcripts subjected to
validation, none were found to be up-regulated in MII oocytes
by real-time PCR analysis. Of particular note, transcripts
included in group D were marginally down-regulated in MII
oocytes as revealed by real-time PCR analysis even though they
appeared to be at higher levels than in GV-stage oocytes bymicroarray analysis (Fig. 2D). This result of real-time PCR
analysis indicates that no transcripts were up-regulated in MII
oocytes and suggests that the detection of the up-regulation of
these 3 transcripts shown in Fig. 2D, as well as the other 43
transcripts suggested to be up-regulated by the microarray data
(Fig. 1), is an artifact. The actual levels of those up-regulated
transcripts in MII oocytes were slightly below levels present in
GVoocytes. Because the amplification system used in this study
minimizes the impact of polyadenylation, the cause of this
artificial increase must have a different etiology. Because total
mRNA in mouse oocytes decreases by at least 30% during
maturation (Paynton et al., 1988), and because equal amounts of
total RNA were used as input into the amplification and
equivalent amounts of resulting cRNA products were applied to
the arrays, some stable transcripts present at MII were probably
applied to the arrays in amounts greater than those present at the
GV stage. Technically, there is no ideal way to avoid this
problem by differential loading because correction for one
group of transcripts would simply distort another. Although we
used a normalization method to correct most of these artifacts
(see Materials and methods), some noise inevitably persists.
Group A transcripts are expressed in expanded cumulus cells
and not oocytes (Fulop et al., 2003; Joyce et al., 2001; Salustri et
al., 1999, 2004; Varani et al., 2002) and are therefore good
indicators of potential cumulus cell contamination of oocyte
RNA preparations. An apparent up-regulation of these tran-
scripts would be detected in MII oocytes if there were any
cumulus cells inadvertently included in the oocyte samples. As
shown in Fig. 2A, none of the four cumulus cell-specific
transcripts, Tnfaip6, Ptx3, Has2 or Ptgs2, was found at higher
levels in MII oocytes by either microarray or real-time RT-PCR
analysis. Moreover, the expression levels of all the cumulus
cell-specific transcripts that were detected in oocytes by either
method were extremely low as shown by their RMA expression
measures or Ct values (data not shown). Thus, there was no
contamination of oocyte RNA preparations with cumulus cells
that could confound interpretation of the microarray results.
Transcripts in group B are normally polyadenylated during
oocyte maturation (Gebauer et al., 1994; Huarte et al., 1987; Oh
et al., 2000; Paynton and Bachvarova, 1994; Sheets et al., 1994)
and could appear to be up-regulated in MII oocytes when poly
(A)-biased mRNA quantification approaches are used to
compare their expression levels in GV and MII oocytes
(Wang et al., 2004). In contrast, no apparent up-regulation
should be detected for any of these transcripts if the method
used for mRNA quantification is unaffected by poly(A) tails as
expected for the Full Spectrum™MultiStart Primers for in vitro
transcription. Indeed, as shown in Fig. 2B, none of these
transcripts was found at levels higher in the MII oocytes than
GV stage by either microarray or by RT-PCR analysis. This
observation provides strong validation for the use of MultiStart
Primers for in vitro transcription to reduce the influence of
polyadenylation. However, real-time PCR but not microarray
detected that all the transcripts in this group were significantly
down-regulated in MII oocytes. This could be due to the
differences in sensitivity or lower limit of detection of these two
methods used for mRNA quantification, or to the overloading of
Fig. 2. Real-time RT-PCR analysis of transcripts selected from microarray expression profiles. Five categories (A–E) of transcripts were selected for real-time RT-PCR
analysis. (A) Transcripts that are normally expressed in expanded cumulus oophorus but not oocytes; (B) transcripts known to be polyadenylated in MII oocytes; (C)
transcripts that are oocyte-specific or highly expressed in oocyte; (D) transcripts that are shown by microarray to be artifactually up-regulated; (E) transcripts that are
shown by microarray to be significantly degraded in MII oocytes. Four sets of samples with equal number of GV and MII oocytes were used for real-time RT-PCR
analysis and data are presented as mean±SEM of log2-transformed fold changes. *p<0.05; MII vs. GV. ND: not detectable.
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Nevertheless, it is consistent that none of these polyadenylated
transcripts was up-regulated in MII oocytes. Two other
transcripts reported to be present at higher levels in MII oocytes
than GV-stage oocytes are Napa (RA81) (Mann et al., 1995)
and Gnai2 (Gαi2) (Rambhatla et al., 1995). The authors
suggested that this apparent increase could be artifactual due to
polyadenylation (Rambhatla et al., 1995). Our microarray
analysis shows no change in the levels of these transcripts at
MII compared with the GV stage supporting the use of the Full
Spectrum™ MultiStart Primers for amplification to avoid
potential complications of polyadenylation.
Transcripts in group C encode proteins that are oocyte-
specific or highly expressed in oocytes and play crucial roles in
promoting the normal development and functions of oocytes
and/or follicles by functioning as paracrine factors, i.e., Gdf9,Bmp15 and Fgf8 (Buratini et al., 2005; Dong et al., 1996;
Eppig, 2001; Matzuk et al., 2002; Su et al., 2004; Valve et al.,
1997; Yan et al., 2001), promoting oocyte-to-embryo transition
as well as preimplantation development, i.e., Zar1, Nalp5 (also
called Mater) (Tong et al., 2000; Wu et al., 2003b), or
potentially regulating chromatin remodeling during oocyte/and
or embryo development, i.e., H1foo (Gao et al., 2004; Tanaka et
al., 2005; Teranishi et al., 2004). Little if anything, however, is
known about the changes in the relative levels of these
transcripts during mouse oocyte maturation. As shown in Fig.
2C, microarray analysis detected the significant down-regula-
tion of Fgf8 in MII oocytes and this down-regulation was
validated by real-time PCR. Although the microarray study
indicated that the rest of the 5 transcripts in group C were not
changed in MII oocytes, real-time RT-PCR analysis revealed
that they were actually all significantly down-regulated. This
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preceding section. Nevertheless, real-time PCR analysis further
confirmed no up-regulation of transcripts in MII oocytes.Transcripts included in group E are representative of those
involved in specific biological function/pathway and/or cellular
process, such as protein synthesis and metabolism (e.g., Rps17,
111Y.-Q. Su et al. / Developmental Biology 302 (2007) 104–117Rps9, Psmc2) and oxidative phosphorylation (e.g., Ndufv1).
For all the transcripts in group E, a similar pattern of change was
consistently revealed by both microarray and real-time PCR
(Fig. 2E). For example, Rps17 was down-regulated as
demonstrated by both microarray and real-time RT-PCR,
31.6- and 45.4-fold, respectively.
In sum, real-time RT-PCR validated (1) the specificity of our
array data allowing the exclusion of potential cumulus cell
contamination from confounding results; (2) the use of the
modified mRNA linear amplification procedure in preventing
profiling errors caused by polyadenylation; (3) no up-regulation
of any transcripts in MII oocytes; and (4) the overall trends of
message stability or loss indicated by microarray analysis.
Biological pathways and functions associated with the
transcripts lost during oocyte maturation
To determine whether there are biological themes and
specificity underlying the degraded oocyte transcripts during
meiotic maturation, we carried out a series of pathway analyses
using both IPA and GenMAPP/MAPPFinder software. IPA is a
Web-based software application that enables the modeling and
analysis of biological systems using microarray data, whereas
GenMAPP/MAPPFinder is a stand-alone computer program
designed for viewing and analyzing gene expression data in the
context of gene ontology and biological pathways. Both
programs are commonly used and demonstrated to be powerful
tools for identifying the biological themes of gene expression
data (Calvano et al., 2005; Dahlquist et al., 2002; Doniger et al.,
2003).
Canonical pathways analysis by IPA identified the pathways
that were significantly associated with the degraded transcripts.
Degraded transcripts as defined by FWER p<0.05 were used
for the analysis. Fisher's exact test was used to calculate a p-
value (<0.05) determining the probability that the association
between the transcripts in the data set and the canonical pathway
could be explained by chance alone. As shown in Fig. 3A, of the
total of 103 metabolic and signaling pathways in the IPA
canonical pathway library, 17 are significantly associated with
the transcripts that were lost in MII oocytes. GenMAPP/
MAPPFinder also identified most of these pathways (see Tables
S1 and S2). Within these 17 canonical pathways, 13 are
involved in metabolic processes. Interestingly, most of these
processes are closely related. For example, 59 transcripts
associated with oxidative phosphorylation were down-regulated
in MII oocytes. The same process, termed “electron transport
chain” in GenMAPP, was identified to be among the most
significantly affected MAPPs as well (see Table S2). As
illustrated in Fig. 3B, oxidative phosphorylation is the majorFig. 3. Canonical pathways associated with the degraded transcripts during oocyte
degraded transcripts. A larger value on the y axis indicates a higher degree of significa
the threshold of significance (p=0.05), bars above this line have a p-value of less tha
shown above the bars. (B) GenMAPP display of degraded transcripts participating in
GVor MII oocytes was uploaded in GenMAPP, and the significantly down-regulate
change) <−1 and were shown in boxes that were marked in orange. The stable transc
indicated in yellow. The transcripts that were up-regulated in MII oocytes as defined b
in green. These designations for presenting data derived from IPA and GenMAPP apathway for conversion of the energy of NADH oxidation into
phosphate-bond energy in ATP. This process takes place in
mitochondria and is catalyzed by five large respiratory enzyme
complexes residing in the mitochondrial inner membrane. Most
of the degraded transcripts that were involved in this pathway
encode these enzyme complexes, indicating the potential for a
reduced rate of ATP production in mature oocytes if the
encoded proteins are rapidly turned over. The second pathway
most impacted by the loss of transcripts was ubiquinone
biosynthesis where 25 transcripts encoding the enzymes that
convert ubiquinol into ubiquinone were involved. Interestingly,
ubiquinone is an essential electron carrier in the oxidative
phosphorylation process; thus, the two canonical pathways
having the highest significance rating by IPA are closely related.
Other canonical pathways, such as pyruvate metabolism and
citrate cycle, are also closely connected to the oxidative
phosphorylation pathway. For example, oocytes efficiently
use pyruvate but not glucose to produce energy essential for
oocyte maturation (Biggers et al., 1967; Downs et al., 2002).
The energy produced by pyruvate metabolism and citrate cycle
is partially in a form of high-energy electrons that are transiently
held by NADH. NADH is then used in the oxidative
phosphorylation pathway in the mitochondrial inner membrane
and the high-energy electrons are eventually used for ATP
synthesis. Therefore, these two pathways are also closely
related to the oxidative phosphorylation process, and the loss of
transcripts involved in these two pathways could result in the
lower rate of ATP synthesis. Because a high rate of oxidative
phosphorylation and ATP production is always associated with
cellular processes that utilizes energy, such as macromolecular
synthesis (e.g., protein synthesis), protein phosphorylation, ion-
transporting, etc., the loss of transcripts responsible for these
processes in MII oocytes could reflect the relatively quiescent
status of MII oocytes in consuming energy. Indeed, it has been
found that oocyte maturation was associated with increased
pyruvate consumption, hence energy utilization; and MII
oocytes consumed less pyruvate than oocytes undergoing
meiotic maturation (Downs et al., 2002). Therefore, it is
possible that loss of relevant transcripts participates in
decreased energy production and utilization apparent in MII
oocytes if the amount of the encoded proteins is also reduced.
The degradation of transcripts involved in energy production
process may also be associated with the relief of ATP
consumption in maintenance of meiotic arrest at the GV stage.
A constant high level of cAMP maintains meiotic arrest in fully-
grown oocytes, and this high level of cAMP is produced from
ATP by an oocyte-specific G-protein-coupled adenyl cyclase
(Eppig et al., 2004; Horner et al., 2003; Mehlmann et al., 2002,
2004). Therefore, the requirement for ATP in maintenance ofmaturation. (A) All the pathways identified by IPA that are associated with the
nce, i.e., a smaller P value. The dark horizontal line crossing all the bars indicates
n 0.05. The number of degraded transcripts that are involved in each pathway is
the oxidative phosphorylation pathway. The list of all the genes detected in either
d transcripts were defined by the criteria of FWER p-value <0.05 and FC (fold
ripts were defined by the criteria as described in Materials and methods and are
y the criteria of FWER p-value <0.05 and FC (fold change) >1 and are indicated
nalyses were also applied in Figs. 4 and 5.
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phosphorylation were highly expressed in GVoocytes as shown
here and elsewhere (Zeng et al., 2004). Taken together, dynamic
changes in the rates of oxidative phosphorylation, energy
production and consumption are tightly correlated with the
meiotic status of the oocyte, and the completion of the first
meiotic division is correlated with the loss of transcripts
involved in these energy producing and using processes.
To further understand the biological and molecular functions
represented by transcripts degraded during the GV to MII
transition, an IPA functional analysis was carried out. This
analysis identified the biological functions that were signifi-
cantly associated with the set of lost transcripts. Degraded
transcripts, as defined by FWER p<0.05 and were associated
with the biological functions in IPA knowledge base, were
considered for the analysis. There were 26 molecular functions
identified by this analysis to be significantly (P<0.05)
associated with the lost transcripts. The top 15 functions are
shown in Fig. 4A. Interestingly, most of the functions identified
by IPA analysis were also independently identified by
GenMAPP/MAPPFinder (Tables S1 and S2) and were well in
agreement with those aforementioned canonical pathways. For
example, the degraded transcripts involved in oxidative
phosphorylation and ubiquinone biosynthesis as identified by
the IPA canonical pathways analysis suggest a low rate of
macromolecule biogenesis in MII oocytes, and this is consistent
with the identification of protein synthesis by the IPA functional
analysis as shown here. In addition, the identification of
pyruvate metabolism and citrate cycle by IPA canonical
pathways analysis indicates low rate of energy production in
MII oocytes, and this is in agreement with the identification of
energy production as a biological function in the IPA functional
analysis. Most interestingly, similar processes were identified
simultaneously by both the IPA canonical pathways analysis
and functional analysis. For example, the nucleotide excision
repair pathway was identified by the IPA canonical pathway
analysis, and the similar process termed DNA replication,
recombination and repair was identified in the IPA functional
analysis.
IPA analysis identified protein synthesis as the function that
is most significantly associated (p=1.1×10−12) with the
degraded transcripts. There were 109 degraded transcripts
involved in this function and they were associated with 7
subcategories of functions (Table S3). Of the degraded
transcripts participating in protein synthesis, a large number
of them encode cytoplasmic and mitochondrial ribosomal
proteins. This function was also identified by GenMAPP
(Table S1) and by MAPPFinder as the most significantly
affected (Table S2). Of the 78 transcripts that encode
cytoplasmic ribosomal proteins in the large and small ribosomal
subunits, 68 of them were significantly degraded in MII oocytes
(Fig. 4B). Coordinate with the loss of mRNAs encoding theFig. 4. Biological functions associated with the degraded transcripts during oocyte
with the degraded transcripts. The number of degraded transcripts involved in eac
identified to be associated with the degraded transcripts, and only the top 15 is sho
ribosomal proteins.ribosomal proteins, there is a decline of about 60 pg/oocyte in
rRNA (Paynton et al., 1988). Presumably, the degradation of
rRNA and transcripts encoding ribosomal proteins results in
loss of ribosomes and reduction in the potential for message
translation. In fact, the absolute rate of protein synthesis
decreases almost 30% during oocyte maturation (Schultz and
Wassarman, 1977). Coordinated with this, transcripts encoding
translation initiation factors are lost; 15 transcripts encoding
translation initiation and translation elongation factors were
significantly degraded during oocyte maturation (Table S3).
While the capacity for protein synthesis becomes reduced
during oocyte maturation, so does protein degradation because
many transcripts encoding the components of the ubiquitin-
proteasome degradation system (12 transcripts in total) were
lost.
There are high levels of expression of transcripts involved in
the regulation of the meiotic cell cycle and DNA repair during
oocyte growth and development (Pan et al., 2005). It is shown
here that many of the transcripts associated with these functions
are degraded during oocyte maturation (Fig. 4A and Tables S1
and S2).
Taken together, results presented here show that transcripts
participating in specific biological pathways and functions
essential for supporting oocyte meiotic arrest, resumption and
progression are highly represented among transcripts degraded
during oocyte maturation. Of particular note are transcripts
associated with protein synthesis and energy production and
utilization. Interestingly, transcripts associated with protein
synthesis are dramatically up-regulated during zygotic gene
activation at the two-cell stage (Zeng and Schultz, 2005). The
explanation for this apparent inefficiency is as lost as the
transcripts.
Biological functions and pathways associated with transcripts
that are relatively stable during oocyte maturation
Despite the substantial loss of transcripts during oocyte
maturation, a great number of transcripts are relatively stable.
Using the statistical strategy described in the section of
Materials and methods, 9260 transcripts were categorized as
stable. To understand the biological functions and processes
represented by these retained transcripts in MII oocytes, this set
of transcripts was subjected to IPA and GenMAPP/MAPPFin-
der analyses. IPA analysis revealed that 30 canonical pathways
were significantly associated with the relatively stable tran-
scripts in MII oocytes (the top 15 is shown in Fig. 5A). Twenty-
five of these (83.33%) were associated with signal transduction.
This was consistent with GenMAPP/MAPPFinder analysis
where cell communication, signal transduction and signal
transducer activity were the most significant MAPPs and gene
ontology (GO) terms associated with stable transcripts (Table
S4 and S5). It is of interest to note that transcripts associatedmaturation. (A) Biological functions identified by IPA that were associated
h function is indicated above the bars. There were 26 functions in total being
wn here. (B) GenMAPP display of degraded transcripts encoding cytoplasmic
Fig. 5. Canonical pathways associated with the stable transcripts during oocyte maturation. (A) Pathways identified by IPA that are associated with the stable
transcripts. The number of stable transcripts involved in each pathway is shown above the bars. There were 30 canonical pathways in total being identified to be
associated with the degraded transcripts, and only the top 15 is shown here. (B) GenMAPP display of transcripts participating in the MAPK signaling pathway.
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degraded in mouse embryos starting from the 1-cell stage and
continuing after zygotic gene activation at 2-cell stage (Zeng
et al., 2004).
IPA analysis revealed that transcripts associated with the
canonical pathways of ERK/MAPK and PI3/AKT signaling
were highly represented in the stable group. These two signaling
pathways are strongly implicated in the regulation of oocyte
meiosis (Choi et al., 1996; Colledge et al., 1994; Hashimoto et
al., 1994; Kalous et al., 2006; Phillips et al., 2002; Su et al.,
2002; Tomek and Smiljakovic, 2005; Verlhac et al., 1996;
Vigneron et al., 2004). The ERK/MAPK signaling pathway is
crucial for the maintenance of MII arrest in oocytes (Colledge et
al., 1994; Hashimoto et al., 1994; Phillips et al., 2002; Su et al.,
2002). Of the 121 transcripts involved in the ERK/MAPK
signaling pathway, 68 (56.19%) was identified as stable. The
display of transcripts involved in MAPK signaling pathway by
GenMAPP was shown in Fig. 5B. Therefore, transcripts
involved in signaling pathways essential for maintaining
meiotic arrest at MII are stable during the GV to MII transition.
Conclusion
To compare transcript profiles between GVand MII oocytes,
one must consider the influence of mRNA polyadenylation and
non-equivalency problems prevalent during GV-to-MII transi-
tion. The modified RNA linear amplification system and the
data normalization method used in the present microarray study
appear to be an effective way of preventing and correcting these
problems. In fact, use of this system may be advantageous when
conducting any transcriptome comparisons where polyadenyla-
tion issues could hamper interpretation, a situation that could be
quite common.
Data presented here indicate that destruction of transcripts
during the GV to MII transition in oocytes is a selective rather
than promiscuous process. Transcripts associated with meiotic
arrest at the GV stage and the progression of oocyte maturation
such as oxidative phosphorylation, energy production and
protein synthesis and metabolism were dramatically degraded.
In contrast, transcripts encoding participants in signaling
pathways essential for maintaining the unique characteristics
of the MII-arrested oocyte, such as those involving protein
kinase pathways, were most prominent among those retained.
Aberrant degradation or maintenance of certain classes of
transcripts during oocyte maturation could be deleterious to
oocyte quality, impacting developmental competence. Although
transcriptional profiling of GV-stage mouse oocytes with
decreased developmental competence did not reveal dramatic
differences from oocytes with high developmental competence
(Pan et al., 2005), differences may become more profound
at MII.
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